Header Leaderboard Ad

Collapse

BGI Shenzhen Acquires Complete Genomics

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • #16
    Originally posted by lh3 View Post
    BGI is not a research institute. It is a company that does some research...
    I think BGI is a complicated entity.

    In addition to its business arm, part of it is also a shi-ye-dan-wei
    http://zh.wikipedia.org/wiki/%E4%BA%...8D%95%E4%BD%8D

    which is similar to a non-profit org.

    I think by acquiring CG, they gain the know-hows of making a sequencer. I think it is likely they will eventually build a sequencer of their own.

    Comment


    • #17
      Originally posted by ymc View Post
      I think BGI is a complicated entity.

      In addition to its business arm, part of it is also a shi-ye-dan-wei
      http://zh.wikipedia.org/wiki/%E4%BA%...8D%95%E4%BD%8D

      which is similar to a non-profit org.

      I think by acquiring CG, they gain the know-hows of making a sequencer. I think it is likely they will eventually build a sequencer of their own.
      If it walks like a duck, quacks like a duck, has feathers like a duck...well, you get the idea.

      Comment


      • #18
        Originally posted by lh3 View Post
        BGI is not a research institute. It is a company that does some research...
        lh3, your description is so concise
        Marco

        Comment


        • #19
          Originally posted by adaptivegenome View Post
          Now BGI gets their US front... And CG is sparred a slow and painful demise...
          not good for everyone ...
          Marco

          Comment


          • #20
            BGI and Gates Foundation Collaborate

            BGI and Gates Foundation Collaborate

            By Bio-IT World Staff

            September 25, 2012 | BGI and the Bill & Melinda Gates Foundation have signed a Memorandum of Understanding (MOU) to begin immediate collaboration on global health and agricultural development.

            “BGI greatly welcomes this opportunity to partner with the Bill & Melinda Gates Foundation to bring the benefit of genomics research to our global society,” said Dr. Huanming Yang, Chairman and Co-Founder of BGI. “We are confident that the combination of our respective capabilities, expertise and experience will yield important scientific breakthroughs in the areas of human, plant and animal genomics that will contribute to the advancement of sustainable health and agriculture development, especially in the developing world.”

            BGI and the Gates Foundation will collaborate on both a strategic level and a specific project level to meaningfully contribute to the achievement of one or more of the United Nations’ Millennium Development Goals. A management committee will be established that will support identification and implementation of collaborations on global health and agricultural development projects.

            Collaboration on specific projects will leverage the Gates Foundation’s agriculture and global health program knowledge and networks with BGI’s sequencing and genomics capabilities to achieve the goal of significantly reducing poverty and/or improving health outcomes in the developing world.

            Strategic objectives include identifying a program of work and collaboration across global health and agricultural development and to conduct work together on initial projects with near-term potential to further develop the working relationship between BGI and the Gates Foundation.

            The agreement supports the prompt and broad dissemination of information from collaboration projects. It also supports broad access to any technology arising from a project. These technologies will be required to be made available at a reasonable cost to the poor.

            "We work closely with partners like BGI to enable breakthroughs in science that will prevent disease and improve agriculture so that farm families can become self-sufficient, reducing hunger and poverty,” said Dr. Trevor Mundel, president of the Global Health Program at the Bill & Melinda Gates Foundation.
            FullGenomes Kit 045DV YFull Terminal SNP Y2846 FTDNA Kit 52277 M35>V12>CTS693>CTS3346>Y2877>CTS6667>CTS8411>Y2846 MTdna U4b1a3a

            Comment


            • #21
              I wonder what exactly they are buying. Is it the machine, ready to go orders, IP clout? I am guessing they are more interested in the ready to go orders, that they can probably churn out at a premium.

              Comment


              • #22
                ... Fast forward 2 years ...

                Is the complete genomics whole genome service still available?
                What is the status of CGI products?

                Was BGI able to salvage anything from this? Or just some patents and the sales force?

                Comment


                • #23
                  Originally posted by Richard Finney View Post
                  ... Fast forward 2 years ...

                  Is the complete genomics whole genome service still available?
                  What is the status of CGI products?

                  Was BGI able to salvage anything from this? Or just some patents and the sales force?
                  They turned CG's machine into BGISEQ-1000.

                  This machine is approved by Chinese Government for clinical use. This is similar to getting FDA 501(k) in the US.

                  The related reagent is approved for NIPT use. I think they are using it to do NIPTs in Chinese hospitals now.

                  Comment

                  Latest Articles

                  Collapse

                  • seqadmin
                    A Brief Overview and Common Challenges in Single-cell Sequencing Analysis
                    by seqadmin


                    ​​​​​​The introduction of single-cell sequencing has advanced the ability to study cell-to-cell heterogeneity. Its use has improved our understanding of somatic mutations1, cell lineages2, cellular diversity and regulation3, and development in multicellular organisms4. Single-cell sequencing encompasses hundreds of techniques with different approaches to studying the genomes, transcriptomes, epigenomes, and other omics of individual cells. The analysis of single-cell sequencing data i...

                    01-24-2023, 01:19 PM
                  • seqadmin
                    Introduction to Single-Cell Sequencing
                    by seqadmin
                    Single-cell sequencing is a technique used to investigate the genome, transcriptome, epigenome, and other omics of individual cells using high-throughput sequencing. This technology has provided many scientific breakthroughs and continues to be applied across many fields, including microbiology, oncology, immunology, neurobiology, precision medicine, and stem cell research.

                    The advancement of single-cell sequencing began in 2009 when Tang et al. investigated the single-cell transcriptomes
                    ...
                    01-09-2023, 03:10 PM

                  ad_right_rmr

                  Collapse
                  Working...
                  X